Medicine

Mansi Chhajed examines how the move from home sleep patterns to disrupted hospital sleep relates to cognitive outcomes after surgery. The session combines longitudinal sleep measurements with clinical assessments of postoperative delirium to identify baseline markers of vulnerability and consider practical ways to improve recovery. It connects sleep architecture, biological and environmental influences, and preoperative risk with proactive, sleep-informed patient care. Chhajed is a Clinical Research Coordinator at Massachusetts General Hospital. Online via Zoom Webinar. Tuesday 29 September 2026 at 14:00 ET / 13:00 CT (America/New_York; EDT, UTC−4). Organized by the Sleep Research Society — Virtual Seminar Series. Follow Register Today on the organizer's page to the event-specific Zoom form, which requests name and email. The form is publicly accessible; advance registration supplies webinar access.

Peter Meikle, Bernie Pope and Tingting Wang present the Australian Cardiovascular disease Data Commons (ACDC). Some heart attacks occur without established risk factors, and repeat events remain common despite optimal treatment. ACDC addresses this gap by securely pooling multi-omics, imaging and longitudinal outcomes from approximately 400,000 people in 18 Australian cohorts. The webinar explains cloud infrastructure, data harmonisation and federated standards based on Gen3; how integrated genomic, multi-omics and imaging cohorts support new risk markers and polygenic risk-score testing; and how the platform can move diagnostic research towards clinical practice. Meikle and Wang are at the Baker Heart and Diabetes Institute; Pope is at Australian BioCommons. Online via Zoom. Wednesday 30 September 2026, 12:00–13:00 AEST (Australia/Melbourne; UTC+10). Free, with advance registration through the official event page. Intended for life scientists, bioinformaticians, cardiovascular clinicians, data custodians and medical data scientists. Parts may be recorded; the Australian BioCommons Code of Conduct applies. Organized by Australian BioCommons.

Ivo D. Dinov examines augmented intelligence as a partnership between people and computational systems. The talk traces the technical and philosophical development of neural networks, then introduces complex-time, or kime, representations and the inference methods they support. Applications include medical imaging, healthcare and economic forecasting. It also considers the academic mission, societal consequences of AI and tensions between rapid technical development and human values, framing mathematical AI methods as extensions of human reasoning. Free hybrid seminar hosted by Wayne State University's Institute for AI and Data Science, AIDaS: CAD Seminar Series. Wednesday 30 September 2026, 14:30–15:30 EDT (America/Detroit; UTC−4). Attend in Room 1146, Faculty/Administration Building, 656 W. Kirby, Detroit, MI 48202, USA, or use the Zoom link on the official event page. Researchers, practitioners, students and faculty are welcome; the organizer encourages in-person attendance.

Anthony Letai discusses how understanding programmed cell death can guide the selection of cancer treatments. The seminar explains how apoptotic signalling can be measured and how these measurements can identify drugs capable of killing cancer cells. Hybrid: New Research Building Auditorium, Georgetown University Medical Center, Washington, DC, and Zoom. Monday 5 October 2026, 16:30–17:30 EDT (America/New_York; UTC−4). Use the attendance registration form or the event’s Zoom link on the organizer page. Organized by Georgetown’s Distinguished Scientist Seminar Series. Letai is Director of the National Cancer Institute. An in-person reception follows the seminar.

Cancer Research UK offers short-term support for clinicians, nurses and allied health professionals to gain early-career cancer-research experience and generate preliminary data before applying for a PhD or MD fellowship.

Investigate smell, taste, reward processing and food motivation in Janina Seubert’s nutritional neuroscience research. Projects use human behavioural experiments and functional MRI, including questions relevant to eating disorders. The position is full time and temporary, based in Solna. Applications close on 28 September 2026 through Karolinska’s recruitment portal. Applicants must have completed their doctorate by the employment decision.

Study molecular markers of vascular cognitive decline and resilience with Anna Marseglia and the Westman group. The project combines proteomics, neuroimaging, cognitive and clinical measures, lifestyle and genetic data from longitudinal cohorts including H70 and UK Biobank. Statistical and machine-learning analyses also address brain-age measures. This two-year full-time appointment is based at Karolinska’s Neo building on the Flemingsberg campus. Apply through the recruitment portal by 29 September 2026.

Three seed awards support innovative brain-cancer projects that are not yet ready for larger funding. Projects should establish feasibility through pilot experiments, initial validation, prototypes or new therapeutic concepts. The application is a one-page proposal explaining the idea, work plan, milestones, budget and route to further development.

This symposium examines how connected research, shared data and lived experience can improve care after brain injury. It spans stroke, traumatic injury, concussion and rehabilitation, linking laboratory work with clinical services and policy. A patient-journey case study examines gaps from emergency retrieval through rehabilitation and long-term community care. Sessions explore data harmonisation, co-design, exercise-related cognition, peer support and translation into practice. Project showcases include AI-supported vocational training, virtual-reality rehabilitation, post-stroke stimulation, concussion assessment and injury biomarkers; a cross-disciplinary pitch competition addresses translation gaps. Named programme contributors include Fatima Nasrallah (QBIC), Daniel Blackmore (Queensland Brain Institute), Robert Cuthbert (UQ RECOVER Injury Research Centre), and Matilde Balbi (Queensland Brain Institute). The organiser’s preliminary programme may change. Thursday 15 October 2026, AEST (Australia/Brisbane): breakfast from 08:00; main symposium 09:00–16:30; networking 16:30–17:30. Venue: TRI Auditorium, Translational Research Institute, 37 Kent Street, Woolloongabba, Queensland. Registration is essential and free, with catering. Virtual access covers only the main symposium and is reserved for delegates outside South East Queensland who cannot travel, including regional Queensland and interstate participants; connection details follow registration. Local delegates should attend in person. The optional 08:15 consumer-council session has limited places and requires separate selection in the form.

Develop antibody-based approaches to Alzheimer’s disease at the Queensland Brain Institute. The project investigates tau-targeting monoclonal antibodies through protein production, cell-based experiments and mouse studies. Responsibilities include analysing results, preparing publications, contributing to funding applications and supporting junior researchers. This full-time appointment runs for up to 12 months, with an immediate start preferred. Annual base pay is AUD 85,373–113,660, plus 17% superannuation.

Lead the development and evaluation of generative-AI tools for perinatal mental health at the Parent-Infant Research Institute. The work combines language-model and chatbot development with assessment of safety, implementation and patient outcomes in digital interventions. It also involves research publications, grants and governance. The appointment is full-time for 12 months, with job sharing considered. Advertised annual salary is AUD 108,820–123,905 pro rata, with applicable allowances, superannuation and salary-packaging benefits.

Recruit high-performing cardiovascular researchers to NSW and support a substantial research programme. This call covers the postdoctoral stream; it is an institution-led research grant rather than a personal fellowship.